到 2027 年欧洲智能吸入器市场 - 按产品(雾化器和吸入器)划分的区域分析和预测;疾病(慢性阻塞性肺病(COPD)和哮喘);最终用户(家庭护理机构以及医院和诊所)和国家/地区

Historic Data: 2016-2017   |   Base Year: 2018   |   Forecast Period: 2019-2027


No. of Pages: 111    |    Report Code: TIPRE00006804    |    Category: Life Sciences

Europe Smart Inhalers Market

欧洲智能吸入器市场预计将从 2018 年的 3.024 亿美元增至 2027 年的 21.2961 亿美元。预计从 2019 年开始,该市场将以 24.9% 的复合年增长率增长 - 2027年。

 

智能吸入器市场的增长是由老年人口增长等因素推动的人口中慢性阻塞性肺病和哮喘的患病率不断上升,人们对健康状况的认识不断提高。然而,由于与网络威胁相关的风险,有关智能吸入器使用的知识有限,市场可能会受到影响。

 

< p>随着城市化的快速发展,各种不利因素不断增加,导致整个欧洲呼吸系统疾病的增加。导致整个欧洲哮喘和慢性阻塞性肺病病例数量增加的一些因素是空气污染水平的上升和吸烟习惯的增加。

 

<空气污染水平的上升一直是发达国家和发展中经济体日益关注的问题。根据世界卫生组织 (WHO) 2018 年 5 月发布的数据,据信每 10 人中有 9 人呼吸含有高浓度污染物的空气。世界卫生组织公布的数据显示,每年约有 700 万人因接触污染空气中的细颗粒而死亡,这些颗粒深入肺部和心血管系统。这会导致多种疾病,如肺癌、肺炎、慢性阻塞性肺病和呼吸道感染等。研究表明,全球90%以上与空气污染相关的死亡发生在东地中海和欧洲地区的低收入和中等收入国家。据世界卫生组织 (WHO) 统计,欧洲地区每年约有 21,000 人因臭氧等空气污染而过早死亡,导致呼吸困难、引发哮喘症状、引发肺病和心脏病。此外,空气污染的间接影响日益增加,例如日益严重的气候变化,因为交通是化石燃料二氧化碳 (CO2) 排放增长最快的来源,而二氧化碳 (CO2) 是气候变化的最大贡献者。根据世界卫生组织 (WHO) 发布的数据,欧盟 (EU) 115 个最大城市中约有 4000 万人暴露在至少一种污染物超过世界卫生组织空气质量指导值的空气中。居住在重型车辆交通繁忙的道路附近的儿童患呼吸系统疾病的风险是居住在交通不太拥堵的街道附近的儿童的两倍。因此,空气污染水平的上升预计将在预测期内推动智能吸入器市场的需求。

 

2018年,按产品划分,吸入器细分市场在智能吸入器市场中占有最大的市场份额。由于哮喘死亡率不断上升,预计吸入器将在 2027 年占据市场份额。预计吸入器细分市场在 2019 年至 2027 年的预测期内也将出现最快的增长率

 

英国预计将引领欧洲地区的市场,因为全国范围内哮喘和慢性阻塞性肺病的患病率不断上升。根据《Asthma UK》公布的数据,2016年至2017年,英国有77,124人因哮喘住院,2017年英国有1,484人死于哮喘发作。因此,考虑到上述因素,在预测期内,该国市场的增长可能会在欧洲地区贡献最大份额。

 < /strong>

2027 年意大利智能吸入器市场收入及预测(百万美元)


 

欧洲智能吸入器 - 市场细分

按产品

  • 吸入器
  • 雾化器

 

因疾病

  • 哮喘
  • < span>慢性阻塞性肺疾病(COPD)

 

< p>

按最终用户

  • 家庭护理设置
  • 医院及诊所

 

按地理位置

  • 欧洲

  • 英国
  • 德国< /span>
  • 法国
  • 西班牙
  • 意大利
 

公司简介

  • < span>葛兰素史克公司
  • Aderium Ltd.
  • Vectura Group plc
  • < span>诺华公司
  • Findair Sp. z oo
  • Cohero Health
  • Crux Product Design Ltd
  • 梯瓦制药
  • 3M
  • Amiko Digital Health Limited

 



Europe Smart Inhalers Strategic Insights

Strategic insights for Europe Smart Inhalers involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-smart-inhalers-market-strategic-framework.webp
Get more information on this report

Europe Smart Inhalers Report Scope

Report Attribute Details
Market size in 2018 US$ 302.40 Million
Market Size by 2027 US$ 2,129.61 Million
Global CAGR (2019 - 2027) 24.9%
Historical Data 2016-2017
Forecast period 2019-2027
Segments Covered By 产品
  • 雾化器和吸入器
By 疾病
  • 慢性阻塞性肺病
By 最终用户
  • 家庭护理环境
  • 医院和诊所
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • GlaxoSmithKline plc
  • Adherium Ltd.
  • Vectura Group plc
  • Novartis AG
  • Findair Sp. z o. o.
  • Cohero Health
  • Crux Product Design Ltd
  • Teva Pharmaceuticals
  • 3M
  • Amiko Digital Health Limited
  • Get more information on this report

    Europe Smart Inhalers Regional Insights

    The regional scope of Europe Smart Inhalers refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-smart-inhalers-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Smart Inhalers Market

    The List of Companies - Europe Smart Inhalers Market

    1. GlaxoSmithKline plc
    2. Adherium Ltd.
    3. Vectura Group plc
    4. Novartis AG
    5. Findair Sp. z o. o.
    6. Cohero Health
    7. Crux Product Design Ltd
    8. Teva Pharmaceuticals
    9. 3M
    10. Amiko Digital Health Limited

     

    Frequently Asked Questions
    How big is the Europe Smart Inhalers Market?

    The Europe Smart Inhalers Market is valued at US$ 302.40 Million in 2018, it is projected to reach US$ 2,129.61 Million by 2027.

    What is the CAGR for Europe Smart Inhalers Market by (2019 - 2027)?

    As per our report Europe Smart Inhalers Market, the market size is valued at US$ 302.40 Million in 2018, projecting it to reach US$ 2,129.61 Million by 2027. This translates to a CAGR of approximately 24.9% during the forecast period.

    What segments are covered in this report?

    The Europe Smart Inhalers Market report typically cover these key segments-

  • 产品 (雾化器和吸入器)
  • 疾病 (慢性阻塞性肺病 (COPD))
  • 最终用户 (家庭护理环境, 医院和诊所)
  • What is the historic period, base year, and forecast period taken for Europe Smart Inhalers Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Smart Inhalers Market report:

  • Historic Period : 2016-2017
  • Base Year : 2018
  • Forecast Period : 2019-2027
  • Who are the major players in Europe Smart Inhalers Market?

    The Europe Smart Inhalers Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • GlaxoSmithKline plc
  • Adherium Ltd.
  • Vectura Group plc
  • Novartis AG
  • Findair Sp. z o. o.
  • Cohero Health
  • Crux Product Design Ltd
  • Teva Pharmaceuticals
  • 3M
  • Amiko Digital Health Limited
  • Who should buy this report?

    The Europe Smart Inhalers Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Smart Inhalers Market value chain can benefit from the information contained in a comprehensive market report.